We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

1,179 hedge funds and large institutions have $50.3B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.53% more ownership

Funds ownership: 0% → 68.53% (+69%)

0% more call options, than puts

Call options by funds: $519M | Put options by funds: $518M

Holders
1,179
Holders Change
+1,179
Holders Change %
–
% of All Funds
38.34%
Holding in Top 10
49
Holding in Top 10 Change
+49
Holding in Top 10 Change %
% of All Funds
1.59%
New
1,179
Increased
–
Reduced
–
Closed
–
Calls
$519M
Puts
$518M
Net Calls
+$1.2M
Net Calls Change
+$1.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

BMY Hedge Fund Activity: Q2 2013 in Review

1,179 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $50.3B.

Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $50.3B of Bristol-Myers Squibb stock for Q2 2013.
  • 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.

Based on aggregated 13F filings for Q2 2013.